Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M828Revenue $M13.6Net Margin (%)-295.8Altman Z-Score1.5
Enterprise Value $M791EPS $-0.7Operating Margin %-311.1Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-295.8Higher ROA y-yN
Price/Book12.810-y EBITDA Growth Rate %-6.8Quick Ratio1.3Cash flow > EarningsY
Price/Sales47.65-y EBITDA Growth Rate %4.1Current Ratio1.3Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-42.6Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-81.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M72.5ROIC % (ttm)-981.9Gross Margin Increase y-yN

Gurus Latest Trades with BCRX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BCRXGeorge Soros 2014-06-30 Sold Out -0.01%$7.37 - $12.52
($9.68)
$ 11.4218%Sold Out0
BCRXGeorge Soros 2014-03-31 Buy 0.01%$7.6 - $12.83
($10.56)
$ 11.428%New holding59,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BCRX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BCRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
STAAB THOMAS R IISenior Vice President and CFO 2015-05-18Sell3,000$113.82 view
Babu Yarlagadda SSenior VP - Drug Discovery 2015-03-19Sell12,105$10.1612.4 view
Babu Yarlagadda SSenior VP - Drug Discovery 2015-03-05Sell37,400$10.597.84 view
Babu Yarlagadda SSenior VP - Drug Discovery 2015-03-04Sell10,495$10.58.76 view
Hutson Nancy JDirector 2015-02-20Buy10,000$10.2711.2 view
Sheridan William PSenior VP - CMO 2014-12-30Sell128,399$12.36-7.61 view
STAAB THOMAS R IISenior Vice President and CFO 2014-12-29Sell9,500$12.56-9.08 view
STAAB THOMAS R IISenior Vice President and CFO 2014-08-27Sell10,000$13.58-15.91 view
STAAB THOMAS R IISenior Vice President and CFO 2014-07-01Sell3,125$13-12.15 view
STAAB THOMAS R IISenior Vice President and CFO 2014-06-23Sell3,125$12.49-8.57 view

Press Releases about BCRX :

    Quarterly/Annual Reports about BCRX:

      News about BCRX:

      Articles On GuruFocus.com
      comment on BCRX Mar 02 2013 
      BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 15 2011 
      BioCryst Pharmaceuticals Inc. Reports Operating Results (10-K/A) Jan 19 2011 
      BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Nov 08 2010 
      BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) Aug 06 2010 
      BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 2,500 Shares Aug 06 2010 
      BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares Jun 04 2010 
      BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q) May 07 2010 
      BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 1,250 Shares May 05 2010 
      BioCryst Pharmaceuticals Inc. (BCRX) SR VP & CFO Stuart Grant sells 38,553 Shares Apr 30 2010 

      More From Other Websites
      BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 22 2015
      BIOCRYST PHARMACEUTICALS INC Financials May 15 2015
      BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 13 2015
      BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary... May 13 2015
      BioCryst Announces Initiation of a Phase 1 Clinical Trial of BCX7353 for the Treatment of Hereditary... May 13 2015
      Oppenheimer Reviews BioCryst Earnings May 11 2015
      10-Q for BioCryst Pharmaceuticals, Inc. May 10 2015
      BioCryst Pharmaceuticals Inc Earnings Call scheduled for 11:00 am ET today May 08 2015
      BIOCRYST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... May 08 2015
      BioCryst reports 1Q loss May 08 2015
      BioCryst reports 1Q loss May 08 2015
      Q1 2015 BioCryst Pharmaceuticals Inc Earnings Release - Before Market Open May 08 2015
      BioCryst Reports First Quarter 2015 Financial Results May 08 2015
      BioCryst to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference May 05 2015
      BioCryst to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference May 05 2015
      These 10 Stocks Could Move Big On Monday May 02 2015
      BioCryst to Announce First Quarter 2015 Financial Results May 8 Apr 23 2015
      BioCryst to Announce First Quarter 2015 Financial Results May 8 Apr 23 2015
      Coverage initiated on BioCryst Pharm by FBR Capital Apr 21 2015
      BioCryst Upgrade Almost Looks Misunderstood Apr 20 2015

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      FEEDBACK